KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 151 filers reported holding KARYOPHARM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,593 | -6.0% | 40,741 | +138.5% | 0.01% | -36.8% |
| Q4 2022 | $58,079 | +81.5% | 17,082 | +188.8% | 0.02% | +18.8% |
| Q3 2022 | $32,000 | -33.3% | 5,914 | -44.2% | 0.02% | -46.7% |
| Q2 2022 | $48,000 | -56.8% | 10,606 | -29.8% | 0.03% | -46.4% |
| Q1 2022 | $111,000 | +19.4% | 15,116 | +4.8% | 0.06% | +30.2% |
| Q4 2021 | $93,000 | +17.7% | 14,427 | +6.9% | 0.04% | -15.7% |
| Q3 2021 | $79,000 | -47.0% | 13,502 | -6.3% | 0.05% | -45.7% |
| Q2 2021 | $149,000 | – | 14,403 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,767,078 | $80,993,000 | 5.22% |
| Palo Alto Investors LP | 4,663,324 | $79,230,000 | 3.17% |
| DOHENY ASSET MANAGEMENT /CA | 282,945 | $4,807,000 | 2.61% |
| Private Capital Advisors, Inc. | 416,900 | $7,083,000 | 2.22% |
| Sandia Holdings, LLC | 119,739 | $2,034,000 | 0.91% |
| Virtus ETF Advisers LLC | 44,986 | $764,000 | 0.68% |
| Birchview Capital, LP | 50,000 | $850,000 | 0.58% |
| Schonfeld Strategic Advisors LLC | 415,600 | $7,061,000 | 0.38% |
| EMERALD ADVISERS, LLC | 561,317 | $9,537,000 | 0.36% |
| Kazazian Asset Management, LLC | 20,672 | $351,000 | 0.32% |